The booming market for weight-loss drugs has propelled Eli Lilly LLY1.16%increase; green up pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...

Amid the pharma industry's breakneck onshoring push this past year, North Carolina has been a major beneficiary as investment announcements rolled in from the likes of Roche, Biogen and Amgen. Now, ...

The clock is up on Biogen’s extra two years of a biosimilar-free U.S. market for its blockbuster multiple sclerosis (MS) med Tysabri. After waiting in the wings post-FDA approval in 2023, Sandoz’s ...

Agentic artificial intelligence company Infinitus Systems is rolling out a new suite designed to support pharmaceutical companies in their direct-to-consumer efforts. Using the platform, Infinitus' ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently put under a microscope. Cramer said that “you’d do very well” owning the stock, as he stated: “If you want to venture beyond what ...